Accelerate Diagnostics Cash Flow - Quarterly (NASDAQ:AXDX)

Add to My Stocks
$21.35 $0.7 (3.17%) AXDX stock closing price Jan 19, 2017 (Closing)

The financial analysis of AXDX requires an investor to check the cash flows for Accelerate Diagnostics. Financials statements like the income statement and balance sheet show that the company has Accelerate Diagnostics profits and Accelerate Diagnostics debt, while the cash flow statement provides details of cash flow movments. The cash flow statement is essetial while conducting the Accelerate Diagnostics cash flow analysis and can be used to measure the operating performance of Accelerate Diagnostics compared to various industry peers like INGN stock and BABY stock. Accelerate Diagnostics has a negative cash and cash equivalents change of $-91.85M. View details of Accelerate Diagnostics cash flows for latest & last 40 quarters.

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Accelerate Diagnostics Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow2M1.27M0.58M1.98M1.34M0.83M0.37M1.15M0.82M0.44M
Net Increase (Decrease) in Assets Liabilities1.12M-0.25M-0.39M--0.24M-0.22M-0.09M1.36M0.01M0.17M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net6.5M3.83M1.68M8.38M5.99M4.18M1.65M9.62M7.33M4.93M
Accelerate Diagnostics Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-2.3M-2.08M-1.68M-3.65M-2.59M-2.16M-1.19M-1.93M-1.35M-0.72M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-49.91M-53.15M-32.81M0.98M-0.97M-0.06M1.95M-1.43M-2.36M-1.95M
Other Cash Inflow (Outflow) from Investment Activities----------
Accelerate Diagnostics Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares0.94M0.09M0.02M104.97M0.54M0.32M0.06M45.79M45.6M45.71M
Issuance (Repayment) of Debt Securities-0.01M-0.01M-0.01M-0.14M-0.11M-0.07M-0.03M-0.1M-0.07M-0.03M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities0.05M0.17M-0.81M-------
Accelerate Diagnostics Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.01M--0.04M-------
Accelerate Diagnostics Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year53.56M30.02M12.06M-0.77M0.28M0.86M1.23M1.39M3M
Cash & Equivalents at Year End28.73M37.51M72.03M120.58M25.19M35.23M47.39M53.56M57.85M65.21M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

Accelerate Diagnostics stock comparison chart provides an easy way to compare the stock price with peers along with details of Accelerate Diagnostics stock price history.
The statement of cash flows can be categorized into three main sections:
  • Accelerate Diagnostics had a Net Change in Cash and Cash Equivalents of $-91.85M for the latest quarter 2016-Q3. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Accelerate Diagnostics stock price , albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Accelerate Diagnostics lost $12.52M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a positive value of $-52.21M for AXDX stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $0.98M for Accelerate Diagnostics.

Key Financial Ratios For Accelerate Diagnostics Cash Flow

FCF margin